Granisetron
Phase 3Completed 0 watching 0 views this weekπ Rising
77
Development Stage
β
Pre-clinicalβ
Phase 1β
Phase 24
Phase 35
ApprovedIndication / Disease
Chemotherapy-induced Nausea and Vomiting
Conditions
Chemotherapy-induced Nausea and Vomiting
Trial Timeline
Jan 1, 2006 β Oct 1, 2006
NCT ID
NCT00273468About Granisetron
Granisetron is a phase 3 stage product being developed by Kyowa Kirin for Chemotherapy-induced Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00273468. Target conditions include Chemotherapy-induced Nausea and Vomiting.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04501211 | Phase 2 | Withdrawn |
| NCT00890565 | Phase 1 | Completed |
| NCT00868764 | Phase 1 | Completed |
| NCT00873197 | Phase 1 | Completed |
| NCT00273468 | Phase 3 | Completed |
Competing Products
20 competing products in Chemotherapy-induced Nausea and Vomiting